hotspot -WSS

hotspot

author：Wikipedia 2025-10-01 00:17:05 - browse：569

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

Biotech startup ReNAgade Therapeutics is cutting staff just seven months after raising the largest Series A round in the industry this year.

ReNAgade launched in May with hopes of becoming a one-stop shop for medicines targeting RNA, the genetic blueprints that cells use to make proteins instrumental in numerous diseases. These types of medicines are in high demand following the advent of mRNA vaccines for Covid and RNA-silencing therapies made by companies like Alnylam Pharmaceuticals.

ReNAgade was able to capitalize on that excitement when it raised a $300 million Series A round led by MPM Capital’s BioImpact Capital and F2 Ventures. But in recent days, the company decided to lay off around 10% of its 100-person team, according to a company statement and former employees’ posts on social media.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

entertainment

WSS

Do digital therapeutics have a future in medicine?

Extensive review finds private equity owners jack up cost of care

Novo Nordisk to expand supply of Wegovy for U.S. patients

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

focus

hotspot

leisure time

Affirmative action in medical school literally saved lives

Woodcock on FDA’s accelerated approval and her next chapter

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

In rare move, senator releases unverified FBI source report alleging Biden bribe

Trump demands the U.S. pay no more for drugs than other countries … again

Stanford president’s abrupt resignation sparks debate

Supreme Court strikes down use of affirmative action

'CMA Fest' 2023: How to watch, who is performing and more

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Scientists grapple with ethics of stem cell research

explore

Caribou posts encouraging results on off

There’s a way to spot data fakery. All journals should be using it

Cognito secures funding to test medical device for Alzheimer's

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

Wikipedia

Wikipedia

entertainment

explore